Filing Details
- Accession Number:
- 0000882104-17-000033
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-03-27 17:51:04
- Reporting Period:
- 2017-03-24
- Filing Date:
- 2017-03-27
- Accepted Time:
- 2017-03-27 17:51:04
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
882104 | Pdl Biopharma Inc. | PDLI | Biological Products, (No Disgnostic Substances) (2836) | 943023969 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1188956 | S Peter Garcia | C/O Pdl Biopharma, Inc. 932 Southwood Blvd. Incline Village NV 89451 | Vice President, Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2017-03-24 | 4,650 | $1.97 | 452,492 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-03-24 | 350 | $1.98 | 452,842 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-03-24 | 10,000 | $1.98 | 462,842 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-03-24 | 5,000 | $1.98 | 467,842 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-03-24 | 5,000 | $1.98 | 472,842 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct |